期刊
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
卷 41, 期 4, 页码 771-779出版社
SAGE PUBLICATIONS INC
DOI: 10.1177/0271678X20928149
关键词
Brain imaging; positron emission tomography; MC-I; kinetic modelling; neurodegeneration
资金
- MIND MAPS consortium
- EPSRC [1965868] Funding Source: UKRI
The study evaluates the test-retest reproducibility of F-18-BCPP-EF in humans, showing its suitability for quantifying MC-I in clinical studies. Results indicate that both DVR-1 and SUVR-1 have improved test-retest variability, with SUVR-1 highly correlated with DVR-1.
Mitochondrial complex I (MC-I) is an essential regulator of brain bioenergetics and can be quantified in the brain using PET radioligand F-18-BCPP-EF. Here we evaluate the test-retest reproducibility of F-18-BCPP-EF in humans, and assess the use of a non-invasive quantification method (standardised uptake value ratio - SUVR). Thirty healthy volunteers had a 90-min dynamic F-18-BCPP-EF scan with arterial blood sampling, five of which received a second scan to be included in the test-retest analysis. Time-activity curves (TAC) were analysed using multilinear analysis 1 (MA1) and the two-tissue compartment model (2TC) to estimate volumes of distribution (V-T). Regional SUVR-1 values were calculated from the 70 to 90-min TAC data using the centrum semiovale as a pseudo reference region, and compared to kinetic analysis-derived outcome measures. The mean absolute test-retest variability of V-T ranged from 12% to 18% across regions. Both DVR-1and SUVR-1 had improved test-retest variability in the range 2%-7%. SUVR-1 was highly correlated with DVR-1 (r(2) = 0.97, n = 30). In conclusion, F-18-BCPP-EF has suitable test-retest reproducibility and can be used to quantify MC-I in clinical studies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据